v3.25.2
FAIR VALUE MEASUREMENT - Narrative (Details)
$ / shares in Units, $ / shares in Units, $ in Thousands, $ in Millions
 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 02, 2021
USD ($)
Jun. 30, 2025
USD ($)
shares
Jun. 30, 2024
USD ($)
shares
Jun. 30, 2025
USD ($)
shares
Jun. 30, 2024
USD ($)
shares
Dec. 31, 2024
USD ($)
Dec. 31, 2021
USD ($)
Jun. 30, 2025
$ / shares
Apr. 06, 2023
USD ($)
$ / shares
shares
Nov. 14, 2022
USD ($)
Nov. 14, 2022
CAD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                      
Change in fair value of financial instruments   $ (1,543) $ 1,140 $ (1,669) $ (720)            
Investment in unconsolidated entity   9,600   9,600   $ 10,800          
Debt interest rate conversion feature   $ 500   $ 500   $ 1,023          
Derivative Asset, Statement of Financial Position [Extensible Enumeration]   SBH purchase option and other derivative assets   SBH purchase option and other derivative assets   SBH purchase option and other derivative assets          
Debt conversion option   $ 664   $ 664   $ 786          
Purchase option $ 8,000           $ 8,000        
Purchase option, term             5 years        
Purchase option, extension term             2 years        
Percentage of outstanding shares             10.00%        
Warrants expiration period             60 days        
Loss on change in fair value of purchase option     34 52 985            
Business combination, purchase option   0   0   52          
Debt Conversion Option                      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                      
Gain (loss) related to debt conversion   83 276 162 220            
Debt conversion option   664   664   786          
Level 3                      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                      
Investment in unconsolidated entity   9,600   9,600   10,800          
Debt interest rate conversion feature   500   500   1,023          
Debt conversion option   0   0   0          
Business combination, purchase option   0   0   52          
Debt Interest Rate Conversion Feature                      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                      
Gain (loss) related to debt conversion   (525) $ (101) (578) $ (154)            
BAT Group | Maximum                      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                      
Accrued interest rate, percentage                   5.00% 5.00%
BAT Group | Minimum                      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                      
Accrued interest rate, percentage                   1.50% 1.50%
BAT Group | Convertible Notes Payable                      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                      
Principal amount   $ 62,962   $ 62,962   58,172       $ 56,800 $ 75.3
Convertible, ownership percentage of shares (as a percent)   19.90%   19.90%              
Conversion price (in CAD per share) | $ / shares               $ 2.00      
DeFloria, LLC                      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                      
Equity method ownership percentage   50.00%   50.00%              
British American Tobacco | DeFloria, LLC                      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                      
Preferred units ownership percentage   100.00%   100.00%              
AJNA Biosciences | DeFloria, LLC                      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                      
Equity method ownership percentage   50.00%   50.00%              
DeFloria, LLC                      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                      
Stockholders' equity note, stock split, conversion ratio       0.1              
DeFloria, LLC                      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                      
Warrants outstanding (in shares) | shares   4,000,000 400,000 4,000,000 400,000            
Change in fair value of financial instruments   $ (1,100) $ 1,000 $ (1,200) $ 200            
Investment in unconsolidated entity   $ 9,600   $ 9,600   10,800          
DeFloria, LLC | Class A Common Stock                      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                      
Class of warrant or right, number of securities called by warrants or rights (in shares) | shares                 865,052    
Warrants exercise price (in USD per share) | $ / shares                 $ 2.89    
DeFloria, LLC | British American Tobacco                      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                      
Preferred units outstanding (in shares) | shares     200,000   200,000       2,000,000    
Capital contributed                 $ 10,000    
Payment for convertible debt           5,000          
DeFloria, LLC | AJNA Biosciences                      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                      
Payment for convertible debt           $ 2,000          
Warrants outstanding (in shares) | shares   4,000,000 400,000 4,000,000 400,000